Effects of Ramipril and Rosiglitazone on Cardiovascular and Renal Outcomes in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: Results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial

Similar Items

• Trial update: the Diabetes REduction Approaches with ramipril and rosiglitazone Medications (DREAM) trial
  by: G. Gulli
  Published: (2013-05-01)
• Incidence of diabetes following ramipril or rosiglitazone withdrawal.
  by: Investigators, D
  Published: (2011)
• Incidence of diabetes following ramipril or rosiglitazone withdrawal
  by: Holman, R, et al.
  Published: (2011)
• Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
  by: Gerstein, H, et al.
  Published: (2006)
• Impaired Secretion of Total Glucagon-like Peptide-1 in People with Impaired Fasting Glucose Combined Impaired Glucose Tolerance
  by: Fang Zhang, Xialian Tang, Hongyi Cao, Qingguo Lü, Nali Li, Yupu Liu, Xiangxun Zhang, Yuwei Zhang, Mingming Cao, Jun Wan, Zhenmei An, Nanwei Tong
  Published: (2012-01-01)